Saber
Device Cardiovascular
General payments
$41,063
Research payments
$0
Through program year 2024, $41,063 in general payments and $0 in research payments were reported against Saber (Cardiovascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $2,497 | 113 |
| 2023 | General | $12,207 | 218 |
| 2022 | General | $3,419 | 96 |
| 2021 | General | $926 | 16 |
| 2020 | General | $11,121 | 86 |
| 2019 | General | $10,894 | 125 |
Breakdown
The top 5 of 97 recipients; each share is of general payments naming this product in 2024.
The top 5 of 16 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 22 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
654 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.